Versor Investments LP Acquires 5,894 Shares of BWX Technologies, Inc. $BWXT

12 May 2026, 07:47 by Scott Moore · The Cerbat Gem

Versor Investments LP grew its holdings in shares of BWX Technologies, Inc. (NYSE:BWXT – Free Report) by 130.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,426 shares of the technology company’s stock after buying an additional 5,894 shares during the quarter. Versor Investments LP’s holdings in BWX Technologies were worth $1,802,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in BWXT. Aventura Private Wealth LLC bought a new stake in BWX Technologies during the 4th quarter worth about $29,000. WFA of San Diego LLC bought a new stake in BWX Technologies during the 2nd quarter worth about $29,000. Global Trust Asset Management LLC bought a new stake in BWX Technologies during the 3rd quarter worth about $32,000. Strategic Advocates LLC acquired a new position in shares of BWX Technologies during the 3rd quarter worth about $32,000. Finally, Strategic Investment Solutions Inc. IL increased its stake in shares of BWX Technologies by 300.0% during the 3rd quarter. Strategic Investment Solutions Inc. IL now owns 200 shares of the technology company’s stock worth $37,000 after purchasing an additional 150 shares during the last quarter. 94.39% of the stock is owned by institutional investors.

Insider Buying and Selling at BWX Technologies

In other BWX Technologies news, CAO Kevin James Gorman sold 1,344 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $214.71, for a total value of $288,570.24. Following the completion of the sale, the chief accounting officer owned 114 shares of the company’s stock, valued at $24,476.94. The trade was a 92.18% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Gerhard F. Burbach sold 1,983 shares of the business’s stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $208.61, for a total transaction of $413,673.63. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 13,327 shares of company stock valued at $2,734,844 in the last quarter. Company insiders own 0.60% of the company’s stock.

BWX Technologies Stock Up 3.0%

Shares of BWXT opened at $211.39 on Tuesday. BWX Technologies, Inc. has a 52 week low of $105.07 and a 52 week high of $241.82. The firm has a market cap of $19.37 billion, a P/E ratio of 56.52, a price-to-earnings-growth ratio of 3.38 and a beta of 0.78. The firm’s 50-day simple moving average is $212.85 and its 200 day simple moving average is $199.68. The company has a debt-to-equity ratio of 1.58, a quick ratio of 2.33 and a current ratio of 2.40.

BWX Technologies (NYSE:BWXT – Get Free Report) last announced its quarterly earnings results on Monday, May 4th. The technology company reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $0.92 by $0.20. BWX Technologies had a net margin of 10.20% and a return on equity of 31.33%. The business had revenue of $860.22 million for the quarter, compared to analyst estimates of $837.47 million. During the same quarter in the prior year, the business earned $0.91 EPS. BWX Technologies’s quarterly revenue was up 26.1% on a year-over-year basis. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. On average, analysts forecast that BWX Technologies, Inc. will post 4.71 earnings per share for the current year.

BWX Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 5th. Shareholders of record on Tuesday, May 19th will be issued a $0.27 dividend. The ex-dividend date of this dividend is Tuesday, May 19th. This represents a $1.08 dividend on an annualized basis and a yield of 0.5%. BWX Technologies’s payout ratio is currently 28.88%.

Wall Street Analyst Weigh In

BWXT has been the topic of several recent analyst reports. BTIG Research boosted their price objective on shares of BWX Technologies from $225.00 to $235.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. TD Cowen initiated coverage on shares of BWX Technologies in a research note on Thursday, March 12th. They set a “buy” rating and a $230.00 price objective on the stock. Wells Fargo & Company initiated coverage on shares of BWX Technologies in a research note on Wednesday, April 1st. They set an “underweight” rating and a $200.00 price objective on the stock. Wall Street Zen upgraded shares of BWX Technologies from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Weiss Ratings upgraded shares of BWX Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, February 25th. Three investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $217.96.

Get Our Latest Report on BWX Technologies

BWX Technologies Company Profile

(Free Report)

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.